日本フィジカルAI新聞

世界のフィジカルAIを、日本語で。

制御理論/ナノロボティクスarXiv:2111.11499

動脈硬化治療のためのナノスケール薬物送達システムのロバスト制御:数理的アプローチ

Robust Control of Nanoscale Drug Delivery System in Atherosclerosis: A Mathematical Approach

シェア:XThreadsFacebookLINEはてブBluesky

動脈壁内の物質輸送を非線形集中定数モデルで表し、スライディングモード制御に基づくナノ粒子の薬物送達を設計、不確実性下での安定性を数学的に証明した論文。

著者: Alireza Rowhanimanesh, Mohammad-R Akbarzadeh-T

分類: eess.SY, cs.RO, cs.SY, q-bio.QM

原文アブストラクト

This paper proposes a mathematical approach for robust control of a nanoscale drug delivery system in treatment of atherosclerosis. First, a new nonlinear lumped model is introduced for mass transport in the arterial wall, and its accuracy is evaluated in comparison with the original distributed-parameter model. Then, based on the notion of sliding-mode control, an abstract model is designed for a smart drug delivery nanoparticle. In contrast to the competing strategies on nanorobotics, the proposed nanoparticles carry simpler hardware to penetrate the interior arterial wall and become more technologically feasible. Finally, from this lumped model and the nonlinear control theory, the overall system's stability is mathematically proven in the presence of uncertainty. Simulation results on a well-known model, and comparisons with earlier benchmark approaches, reveals that even when the LDL concentration in the lumen is high, the proposed nanoscale drug delivery system successfully reduces the drug consumption levels by as much as 16% and the LDL level in the Endothelium, Intima, Internal Elastic Layer (IEL) and Media layers of an unhealthy arterial wall by as much as 14.6%, 50.5%, 51.8%, and 64.4%, respectively.

  1. 1Boston Dynamics、車輪付きAtlasの研究試作機を紹介研究・技術
  2. 2newmoとKDDIが資本業務提携 2028年に堺市で自動運転タクシー商用化目指す提携・買収
  3. 3Google DeepMind、ロボット向けAIを発表新製品・発表
  4. 4NVIDIA、CoRLでGR00T 2とIsaac Lab 3.0を発表新製品・発表
  5. 5GXOとApptronik、Apolloの物流現場試験を拡大 最大1,000台の展開を構想量産・展開

PR・アフィリエイト広告

FRONTIER(GPU搭載BTOパソコン)

FRONTIER(GPU搭載BTOパソコン)の公式広告バナーFRONTIERでGPU搭載PCを見る ↗
PR本紙発行元 EmplifAI